2-47800616-T-C

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2

The NM_001406795.1(MSH6):​c.2729T>C​(p.Val910Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00574 in 1,614,190 control chromosomes in the GnomAD database, including 45 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V910G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0046 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0059 ( 40 hom. )

Consequence

MSH6
NM_001406795.1 missense

Scores

17

Clinical Significance

Benign reviewed by expert panel U:2B:34O:1

Conservation

PhyloP100: 0.373

Publications

64 publications found
Variant links:
Genes affected
MSH6 (HGNC:7329): (mutS homolog 6) This gene encodes a member of the DNA mismatch repair MutS family. In E. coli, the MutS protein helps in the recognition of mismatched nucleotides prior to their repair. A highly conserved region of approximately 150 aa, called the Walker-A adenine nucleotide binding motif, exists in MutS homologs. The encoded protein heterodimerizes with MSH2 to form a mismatch recognition complex that functions as a bidirectional molecular switch that exchanges ADP and ATP as DNA mismatches are bound and dissociated. Mutations in this gene may be associated with hereditary nonpolyposis colon cancer, colorectal cancer, and endometrial cancer. Transcripts variants encoding different isoforms have been described. [provided by RefSeq, Jul 2013]
FBXO11 (HGNC:13590): (F-box protein 11) This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class. It can function as an arginine methyltransferase that symmetrically dimethylates arginine residues, and it acts as an adaptor protein to mediate the neddylation of p53, which leads to the suppression of p53 function. This gene is known to be down-regulated in melanocytes from patients with vitiligo, a skin disorder that results in depigmentation. Polymorphisms in this gene are associated with chronic otitis media with effusion and recurrent otitis media (COME/ROM), a hearing loss disorder, and the knockout of the homologous mouse gene results in the deaf mouse mutant Jeff (Jf), a single gene model of otitis media. Alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jun 2010]
FBXO11 Gene-Disease associations (from GenCC):
  • intellectual developmental disorder with dysmorphic facies and behavioral abnormalities
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 8 benign, 47 uncertain in NM_001406795.1
BP4
Computational evidence support a benign effect (MetaRNN=0.035881698).
BP6
Variant 2-47800616-T-C is Benign according to our data. Variant chr2-47800616-T-C is described in ClinVar as Benign. ClinVar VariationId is 8931.Status of the report is reviewed_by_expert_panel, 3 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00462 (704/152330) while in subpopulation AMR AF = 0.00732 (112/15300). AF 95% confidence interval is 0.00662. There are 5 homozygotes in GnomAd4. There are 348 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001406795.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH6
NM_000179.3
MANE Select
c.2633T>Cp.Val878Ala
missense
Exon 4 of 10NP_000170.1
MSH6
NM_001406795.1
c.2729T>Cp.Val910Ala
missense
Exon 5 of 11NP_001393724.1
MSH6
NM_001406813.1
c.2639T>Cp.Val880Ala
missense
Exon 4 of 10NP_001393742.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH6
ENST00000234420.11
TSL:1 MANE Select
c.2633T>Cp.Val878Ala
missense
Exon 4 of 10ENSP00000234420.5
MSH6
ENST00000445503.5
TSL:1
n.*1980T>C
non_coding_transcript_exon
Exon 3 of 9ENSP00000405294.1
MSH6
ENST00000445503.5
TSL:1
n.*1980T>C
3_prime_UTR
Exon 3 of 9ENSP00000405294.1

Frequencies

GnomAD3 genomes
AF:
0.00465
AC:
708
AN:
152212
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000821
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.00733
Gnomad ASJ
AF:
0.00691
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00517
Gnomad FIN
AF:
0.000659
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00716
Gnomad OTH
AF:
0.00718
GnomAD2 exomes
AF:
0.00511
AC:
1280
AN:
250386
AF XY:
0.00559
show subpopulations
Gnomad AFR exome
AF:
0.000879
Gnomad AMR exome
AF:
0.00324
Gnomad ASJ exome
AF:
0.0104
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.000693
Gnomad NFE exome
AF:
0.00707
Gnomad OTH exome
AF:
0.00656
GnomAD4 exome
AF:
0.00586
AC:
8568
AN:
1461860
Hom.:
40
Cov.:
34
AF XY:
0.00607
AC XY:
4411
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.000806
AC:
27
AN:
33480
American (AMR)
AF:
0.00342
AC:
153
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00999
AC:
261
AN:
26134
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39698
South Asian (SAS)
AF:
0.00650
AC:
561
AN:
86254
European-Finnish (FIN)
AF:
0.000749
AC:
40
AN:
53412
Middle Eastern (MID)
AF:
0.0170
AC:
98
AN:
5768
European-Non Finnish (NFE)
AF:
0.00640
AC:
7114
AN:
1111994
Other (OTH)
AF:
0.00517
AC:
312
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
494
988
1483
1977
2471
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
266
532
798
1064
1330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00462
AC:
704
AN:
152330
Hom.:
5
Cov.:
32
AF XY:
0.00467
AC XY:
348
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.000818
AC:
34
AN:
41560
American (AMR)
AF:
0.00732
AC:
112
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00691
AC:
24
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00518
AC:
25
AN:
4828
European-Finnish (FIN)
AF:
0.000659
AC:
7
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00714
AC:
486
AN:
68036
Other (OTH)
AF:
0.00663
AC:
14
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
41
81
122
162
203
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00597
Hom.:
14
Bravo
AF:
0.00446
TwinsUK
AF:
0.00701
AC:
26
ALSPAC
AF:
0.00752
AC:
29
ESP6500AA
AF:
0.00113
AC:
5
ESP6500EA
AF:
0.00767
AC:
66
ExAC
AF:
0.00524
AC:
636
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
11
not specified (12)
-
2
6
Lynch syndrome 5 (8)
-
-
5
Hereditary cancer-predisposing syndrome (5)
-
-
4
not provided (4)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
Carcinoma of colon (1)
-
-
1
Colorectal / endometrial cancer (1)
-
-
1
Endometrial carcinoma;C1833477:Lynch syndrome 5;C5436807:Mismatch repair cancer syndrome 3 (1)
-
-
1
Hereditary breast ovarian cancer syndrome (1)
-
-
1
Hereditary nonpolyposis colorectal neoplasms (1)
-
-
1
Lynch syndrome (1)
-
-
1
Malignant tumor of breast (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.25
CADD
Benign
8.0
DANN
Benign
0.73
DEOGEN2
Benign
0.41
T
Eigen
Benign
-0.87
Eigen_PC
Benign
-0.86
FATHMM_MKL
Benign
0.52
D
LIST_S2
Benign
0.75
T
MetaRNN
Benign
0.036
T
MetaSVM
Benign
-0.37
T
MutationAssessor
Benign
1.1
L
PhyloP100
0.37
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-1.2
N
REVEL
Benign
0.15
Sift
Benign
0.34
T
Sift4G
Benign
0.48
T
Polyphen
0.036
B
Vest4
0.17
MVP
0.85
ClinPred
0.0017
T
GERP RS
2.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.27
gMVP
0.45
Mutation Taster
=65/35
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2020912; hg19: chr2-48027755; COSMIC: COSV52276766; COSMIC: COSV52276766; API